BeForPharma Information

[FUNDRAISING] Established in Bari in 2014, Beforpharma provides radiopharmaceutical services to public and private nuclear medicine companies and healthcare institutions in Italy and globally. The company specializes in radiopharmaceutical research and production, having successfully executed projects in 10 different countries. The range of services has varied, encompassing GMP and quality control consulting, regulatory affairs, training, as well as project management for radiopharmaceutical facilities construction overseas. In February 2023, Beforpharma secured a patent for the radiolabeling process of 68Ga-PSMA radiopharmaceutical. Currently, Beforpharma is involved in small-scale preparation of radiopharmaceuticals (in particular, 68Ga-PSMA and 68Ga-DOTATOC) at the hospital radiopharmacy.